Αρχειοθήκη ιστολογίου

Τρίτη 20 Ιουνίου 2017

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Conditions:   Activating RAS Mutation;   Juvenile Myelomonocytic Leukemia;   Monosomy 7;   Neurofibromatosis Type 1;   NF1 Gene Mutation;   PTPN11 Gene Mutation;   Splenomegaly Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Trametinib Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sT5GlR
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader